On the 40th anniversary of the Chernobyl disaster, POWER sent a freelance photographer and correspondent to the site in ...

Convergent Therapeutics' Dr. Philip Kantoff and Plus Therapeutics' Dr. Marc Hedrick discuss how unmet medical needs, maturing ...

In a major step toward self-sufficiency in advanced cancer care, scientists at a premier Chinese research facility say they ...

Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® today announced that an abstract presenting results of two ...

When Florida State University began moving students and faculty out of the historic Dittmer Chemistry Lab building in the ...

Alpha Tau’s IMPACT trial is expected to enroll up to 30 patients across the U.S., Canada, and Israel, focusing on patients ...

IAEA Deputy Director General Najat Mokhtar described the laboratory as a “trusted and high-performing partner,” highlighting its long-standing contributions to global environmental monitoring.

Alpha isotopes, often described as the "nuclear warhead against cancer", possess high-energy, short-range properties that precisely destroy cancer cells with minimal damage to healthy tissue, offering ...

Now, the China Spallation Neutron Source — a major national scientific facility in Dongguan, Guangdong province — has ...

A triple-drug regimen combining two immunotherapy agents with radiation before surgery appears to activate immune defenses ...

With a market size anticipated to expand from $0.62 billion in 2025 to $0.67 billion in 2026 at a compound annual growth rate ...

Using sintered lunar regolith for heat storage, Harbin Institute of Technology researchers demonstrate how a closed Brayton ...